ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

PNT POINT Biopharma Global Inc

12.50
0.00 (0.00%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
POINT Biopharma Global Inc PNT 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 12.50 09:00:00
개장가 저가 고가 종가 전일 종가
12.50 12.50
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
08/01/202421:00EDGAR2Form 15-12G - Securities registration termination [Section..
03/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
28/12/202307:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202307:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202307:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202307:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202307:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202307:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202307:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202307:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202323:44EDGAR2Form POS AM - Post-Effective amendments for registration..
27/12/202323:43EDGAR2Form POS AM - Post-Effective amendments for registration..
27/12/202323:42EDGAR2Form S-8 POS - Securities to be offered to employees in..
27/12/202322:54EDGAR2Form 8-K - Current report
27/12/202322:31PRNUSLilly Completes Acquisition of POINT Biopharma
18/12/202322:14EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
18/12/202321:30GLOBELantheus and POINT Biopharma Announce Positive Topline..
18/12/202320:45PRNUSLilly Extends Tender Offer to Acquire POINT Biopharma to..
05/12/202320:25IHMARKETNEWSMoody’s Reassesses China, GitLab Exceeds Estimates, Twilio..
04/12/202321:22EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
04/12/202320:45PRNUSLilly Extends Tender Offer to Acquire POINT Biopharma to..
17/11/202321:05EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
17/11/202320:45PRNUSLilly Extends Tender Offer to Acquire POINT Biopharma to..
15/11/202321:00EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
15/11/202306:33PRNUSLilly Announces the Receipt of NRC Consent in Connection..
13/11/202321:30GLOBEPOINT Biopharma Reports Third Quarter 2023 Financial Results..
13/11/202321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202307:28EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
09/11/202306:56PRNUSLilly Announces Extension of Tender Offer to Acquire POINT..
08/11/202308:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202305:40EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
28/10/202305:20EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
13/10/202320:11EDGAR2Form SC 14D9 - Solicitation, recommendation statements
04/10/202306:24EDGAR2Form SC14D9C - Written communication relating to third party..
03/10/202323:03IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
03/10/202320:37EDGAR2Form SC14D9C - Written communication relating to third party..
03/10/202320:35EDGAR2Form 8-K - Current report
03/10/202319:45PRNUSLilly to Acquire POINT Biopharma to Expand Oncology..
18/09/202321:00GLOBEPOINT Biopharma and Athebio Announce Partnership to Develop..
14/08/202323:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/08/202320:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/08/202320:30GLOBEPOINT Biopharma Reports Second Quarter 2023 Financial..
14/08/202320:21EDGAR2Form 8-K - Current report
04/08/202305:05EDGAR2Form 8-K - Current report
31/07/202322:00GLOBEITM and POINT Biopharma Expand Global Supply Agreement for..
26/06/202320:45GLOBEPOINT Biopharma and AdvanCell to Collaborate in the..
26/06/202320:30GLOBEPOINT Biopharma Expands Its Research with Next-Generation..
12/06/202321:00GLOBEPOINT Biopharma Announces Appointment of Dr. Bridget Martell..
07/06/202320:00GLOBEPOINT Biopharma to Host Virtual Investor Day on Tuesday,..

최근 히스토리

Delayed Upgrade Clock